Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -569.77%-2.66M | -276.11%-3.04M | -450.68%-2.83M | 33.84%-2.42M | -143.74%-697K | 90.10%-397K | 34.26%-808K | -10,086.66%-513K | -7.97%-3.65M | 81.02%1.59M |
| Net income from continuing operations | 285.36%2.42M | 119.08%796K | -1,164.98%-13.51M | -290.07%-21.43M | -7,897.14%-14.88M | -613.70%-1.31M | -132.96%-4.17M | 26.47%-1.07M | 160.70%11.27M | 98.82%-186.08K |
| Operating gains losses | 525.79%941K | -881.59%-3.06M | 6.04%685K | 171.67%13.41M | 2,397.28%12.59M | 92.66%-221K | --391K | --646K | ---18.71M | ---548.08K |
| Depreciation and amortization | 533.33%76K | 1,380.00%74K | --10K | -27.78%26K | 2,635.56%9K | --12K | --5K | --0 | 199.43%36K | -88.31%329 |
| Remuneration paid in stock | ---- | ---- | ---- | 105.56%148K | -103.65%-87.91K | 106.71%157.09K | --33.22K | --45.6K | --72K | --2.41M |
| Unrealized gains and losses of investment securities | -1,780.12%-3.12M | ---- | ---- | -15,050.00%-909K | -26,620.49%-1.39M | ---166K | -700.00%-2.14K | -713.18%-4.32K | -350.63%-6K | -5,744.94%-5.2K |
| Remuneration paid in stock | 1,061.97%825K | 805.00%724K | 2,114.71%1.51M | -7.38%339K | 44.91%120K | -34.93%71K | -7.34%80K | -22.50%68K | 14.15%366K | -21.98%82.81K |
| Deferred tax | --2.85M | ---- | ---- | 246.14%1.14M | 790.47%1.14M | --0 | -1,305.42%-413.25K | 77.02%-62.46K | -117.12%-778K | -104.32%-164.67K |
| Other non cashItems | -668.84%-6.9M | -570.84%-11.58M | 3,117.86%8.45M | 57.20%4.45M | -34.01%1.06M | 19.78%1.21M | 18,367.89%2.46M | -240.19%-280K | 4,808.15%2.83M | --1.61M |
| Change In working capital | 24,900.00%248K | -35.16%-296K | -71.90%34K | -67.51%410K | 131.74%509K | -100.36%-1K | -118.41%-219K | -91.34%121K | 275.80%1.26M | -194.94%-1.6M |
| -Change in receivables | -4,603.45%-1.36M | -236.65%-744K | -121.31%-130K | -72.99%255K | -204.31%-105K | 95.29%-29K | -113.24%-221K | 390.53%610K | 1,145.78%944K | -89.44%100.66K |
| -Change in prepaid assets | ---- | ---- | ---- | ---- | ---- | -1.77%58.43K | 97.73%-4.75K | -104.26%-52.64K | ---- | ---- |
| -Change in payables and accrued expense | 4,640.00%1.36M | 15,050.00%909K | 134.17%149K | 163.16%168K | 152.31%628K | -103.59%-30K | 102.22%6K | -217.98%-436K | -136.93%-266K | -247.61%-1.2M |
| -Change in other current assets | 331.03%250K | -11,425.00%-461K | 128.30%15K | -102.23%-13K | ---14K | --58K | ---4K | ---53K | --584K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -569.77%-2.66M | -276.11%-3.04M | -450.68%-2.83M | 33.84%-2.42M | -143.74%-697K | 90.10%-397K | 34.26%-808K | -10,086.66%-513K | -7.97%-3.65M | 81.02%1.59M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -800.51%-19.32M | -768.86%-9.79M | -108.61%-502K | 106.80%421K | 26.71%-2.14M | -17.26%-2.15M | -117.56%-1.13M | 174.23%5.83M | 64.76%-6.19M | 61.22%-2.92M |
| Net PPE purchase and sale | -683.07%-17.25M | -767.59%-10.6M | -33.02%-1.13M | 44.00%-5.9M | -108.32%-1.63M | -20.44%-2.2M | -1,643.50%-1.22M | 89.21%-848K | 39.99%-10.54M | 89.61%-781.96K |
| Net business purchase and sale | ---2.75M | --0 | --0 | 2.71%6.66M | --0 | --0 | --0 | --6.66M | --6.49M | --2 |
| Net investment purchase and sale | ---1K | --0 | --30K | ---1.01M | ---1.01M | --0 | --0 | --0 | --0 | ---- |
| Interest received (cash flow from investment activities) | 1,082.76%686K | 752.63%810K | 3,405.88%596K | 203.64%668K | --498K | --58K | --95K | --17K | --220K | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2.36M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -800.51%-19.32M | -768.86%-9.79M | -108.61%-502K | 106.80%421K | 26.71%-2.14M | -17.26%-2.15M | -117.56%-1.13M | 174.23%5.83M | 64.76%-6.19M | 61.22%-2.92M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -282K | -109K | -829K | 1,109.57%101.98M | 3,078,246.69%101.98M | 0 | 0 | 0 | -51.96%8.43M | -100.06%-3.31K |
| Net issuance payments of debt | ---87K | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -92.85%429K | -100.00%-260 |
| Net common stock issuance | ---- | ---- | ---833K | 1,172.54%101.83M | 20,547.59%101.83M | --0 | --0 | --0 | -36.74%8M | ---498K |
| Proceeds from stock option exercised by employees | --0 | --130K | --4K | --150K | --150K | --0 | --0 | --0 | --0 | ---- |
| Net other financing activities | ---195K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---282K | ---109K | ---829K | 1,109.57%101.98M | 3,078,246.69%101.98M | --0 | --0 | --0 | -51.96%8.43M | -100.06%-3.31K |
| Net cash flow | ||||||||||
| Beginning cash position | 1,572.47%84.56M | 1,294.65%97.5M | 5,983.54%101.66M | -45.73%1.67M | -16.22%2.51M | -12.90%5.06M | 264.86%6.99M | -45.73%1.67M | -52.41%3.08M | -19.50%3M |
| Current changes in cash | -775.57%-22.26M | -568.73%-12.94M | -178.12%-4.16M | 7,201.21%99.99M | 7,555.22%99.14M | 9.36%-2.54M | -149.76%-1.94M | 557.52%5.32M | 58.48%-1.41M | -105.02%-1.33M |
| End cash Position | 2,378.24%62.3M | 1,572.47%84.56M | 1,294.65%97.5M | 5,983.54%101.66M | 5,983.54%101.66M | -16.22%2.51M | -12.90%5.06M | 264.86%6.99M | -45.73%1.67M | -45.73%1.67M |
| Free cash from | -665.77%-19.91M | -571.97%-13.64M | -190.45%-3.95M | 41.38%-8.32M | -386.64%-2.33M | 55.47%-2.6M | -56.26%-2.03M | 82.69%-1.36M | 48.29%-14.19M | 112.21%811.48K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.